Drug recall · November 17, 2021
Tadalafil Tablets recall
Why: Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-077-01
- Lots / codes
Lot # DNC0814A, DNC0815A, Exp. Date 04/2023
- Quantity
- 36,786 30-count bottles
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- Distributed to one distributor who may have further distribute the product nationwide.
- Initiated
- October 25, 2021 · Voluntary: Firm initiated
- Classified
- November 12, 2021
- Reported
- November 17, 2021
- Ended
- September 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tadalafil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.